The latest update is out from Fortress Biotech (FBIO).
During the 2024 Annual Meeting held virtually on May 23, Fortress Company’s stockholders approved five key proposals. These included the election of eight directors for the following year, the ratification of KPMG LLP as the company’s independent auditors, as well as amendments to the Incentive Plan, Employee Stock Purchase Plan (ESPP), and Long-Term Incentive Plan (LTIP) to increase available shares and extend the LTIP’s term. The proposals received substantial support, with the majority of votes cast in favor, signifying strong shareholder confidence in the company’s governance and future incentive strategies.
For detailed information about FBIO stock, go to TipRanks’ Stock Analysis page.
